Identification of BATF function and targets during NK cell activation

NK 细胞激活过程中 BATF 功能和靶标的鉴定

基本信息

  • 批准号:
    10494220
  • 负责人:
  • 金额:
    $ 24.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-23 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Natural killer (NK) cells play essential roles in the immune response to intracellular pathogens, including viruses and bacteria, and form an important defense against malignant transformation and metastasis. NK cells are activated when they detect an imbalance in the signals from receptors on their cell surface, either a loss of inhibitory signals or activation through activating receptors including cytokine receptors. Alterations in these signaling pathways impact the transcriptional regulatory networks that contribute to NK cell activation and effector function. At the present time there is a gap in our knowledge of the major transcription factors that are impacted by these signaling pathways and how they modulate NK cell function. In this R21 application, we present data to support the hypothesis that Batf, the founding member of the AP-1 family of transcription factors, is induced by proinflammatory cytokine signaling in NK cells and impacts multiple aspects of the NK cell response. In aim 1, we will test the hypothesis that Batf regulates key genes involved in NK cell expansion, survival, and effector function by identifying direct Batf targets during the response to mouse cytomegalovirus. In aim 2, we will test the hypothesis that Batf plays unique roles in different NK cell activating contexts by testing the requirement for Batf in the NK cell response to metastatic melanoma and in a solid tumor model that relies on NK cell migration and chemokine production. Taken together, these studies will provide a broad view of the requirements for Batf in distinct NK cell activation contexts and lead to the identification of Batf targets that underlie its essential functions.
项目摘要 自然杀伤(NK)细胞在对细胞内病原体的免疫应答中起重要作用, 包括病毒和细菌,并形成一个重要的防御恶性转化 和转移。当NK细胞检测到来自细胞的信号不平衡时, 受体在其细胞表面,无论是抑制信号的损失或激活,通过激活 受体,包括细胞因子受体。这些信号通路的改变会影响 转录调控网络有助于NK细胞活化和效应子功能。在 目前,我们对主要转录因子的认识存在空白, 受这些信号通路的影响以及它们如何调节NK细胞功能。在R21中 应用程序,我们提出的数据支持的假设,Batf,创始成员的 AP-1家族转录因子,由NK细胞中的促炎细胞因子信号传导诱导 并影响NK细胞反应的多个方面。在目标1中,我们将检验以下假设: Batf通过以下途径调节NK细胞扩增、存活和效应子功能相关的关键基因: 在对小鼠巨细胞病毒的应答期间鉴定直接Batf靶标。在目标2中,我们 通过测试来检验Batf在不同NK细胞活化背景下发挥独特作用的假设 在NK细胞对转移性黑色素瘤的应答和实体瘤中对Batf的需求 依赖于NK细胞迁移和趋化因子产生的模型。综合来看,这些研究 将提供在不同NK细胞活化背景下对Batf的要求的广泛观点, 导致确定作为其基本功能基础的Batf目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BARBARA L. KEE其他文献

BARBARA L. KEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BARBARA L. KEE', 18)}}的其他基金

Investigating Helios as a regulator of natural killer cell effector maturation
研究 Helios 作为自然杀伤细胞效应成熟的调节剂
  • 批准号:
    10608673
  • 财政年份:
    2023
  • 资助金额:
    $ 24.6万
  • 项目类别:
Identification of BATF function and targets during NK cell activation
NK 细胞激活过程中 BATF 功能和靶标的鉴定
  • 批准号:
    10354363
  • 财政年份:
    2021
  • 资助金额:
    $ 24.6万
  • 项目类别:
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
E蛋白转录因子依赖性iNKT细胞扩增和分化的机制
  • 批准号:
    9242168
  • 财政年份:
    2016
  • 资助金额:
    $ 24.6万
  • 项目类别:
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
E蛋白转录因子依赖性iNKT细胞扩增和分化的机制
  • 批准号:
    10065488
  • 财政年份:
    2016
  • 资助金额:
    $ 24.6万
  • 项目类别:
Molecular Mechanisms of Invariant Natural Killer T Cell Differentiation
恒定自然杀伤T细胞分化的分子机制
  • 批准号:
    10627307
  • 财政年份:
    2016
  • 资助金额:
    $ 24.6万
  • 项目类别:
Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis
免疫缺陷在E2A-/- T细胞淋巴瘤发生中的作用分析
  • 批准号:
    8959799
  • 财政年份:
    2015
  • 资助金额:
    $ 24.6万
  • 项目类别:
EZH2 in lymphoid lineage specification and commitment
EZH2 淋巴谱系规范和承诺
  • 批准号:
    8622415
  • 财政年份:
    2014
  • 资助金额:
    $ 24.6万
  • 项目类别:
Transcriptional Control of Natural Killer Cell Development
自然杀伤细胞发育的转录控制
  • 批准号:
    10540688
  • 财政年份:
    2014
  • 资助金额:
    $ 24.6万
  • 项目类别:
Regulation of Lymphocyte Development by HLH Proteins
HLH 蛋白对淋巴细胞发育的调节
  • 批准号:
    8791299
  • 财政年份:
    2014
  • 资助金额:
    $ 24.6万
  • 项目类别:
Regulation of Lymphocyte Development by HLH Proteins
HLH 蛋白对淋巴细胞发育的调节
  • 批准号:
    8638491
  • 财政年份:
    2014
  • 资助金额:
    $ 24.6万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.6万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.6万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.6万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.6万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.6万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.6万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.6万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.6万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.6万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了